home / stock / xhs / xhs news


XHS News and Press, SPDR S&P Health Care Services From 10/04/22

Stock Information

Company Name: SPDR S&P Health Care Services
Stock Symbol: XHS
Market: NYSE

Menu

XHS XHS Quote XHS Short XHS News XHS Articles XHS Message Board
Get XHS Alerts

News, Short Squeeze, Breakout and More Instantly...

XHS - Sector Views: S&P 500 Sensitivity To Global Factors

Summary We expect macro headwinds will continue to pressure U.S. corporate earnings in the coming months. We expect earnings expectations to decline as multinational firms realize foreign exchange headwinds that accelerated over the past year. Investors can avoid undue interna...

XHS - A Stock Picker's Guide To Inflation

Summary With inflation at the highest level in decades and volatility continuing to surge, equity investors are questioning their next moves. At the beginning of the year, financial conditions were very loose by any means historically, and we've very rapidly moved from loose finan...

XHS - Global X House Views - September

Summary Jackson Hole reset expectations to focus more on inflation. The U.S. dollar should stabilize over the medium-term amid hawkishness from other central banks and slowing economic data. At stake is Europe’s ability to refill their storage tanks ahead of winter. ...

XHS - Sector Views: Free Cash Is King

Summary We believe that cash flow and debt sustainability are likely to become increasingly important as real economic growth slows and credit access tightens. Cash flow provides a link between a company’s income statement and their balance sheet. Focusing on the Russel...

XHS - Market X-Ray - The Big Bounce Fades

Summary Today's market X-ray shows the returns for each index, asset class, sector, and so on, since the recent low point on June 16th. Of the global indices, US small caps are in the lead, followed by the NASDAQ. High beta stocks are the most preferred factors since June 16. ...

XHS - What The Inflation Reduction Act Means For Drug Prices

Summary The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry’s long-term financial performance. The legislation caps out-of-pocket costs for Medicare prescriptions at $2,000 per year, starting in 2025. ...

XHS - Why Health Care Stocks May Be Poised To Beat The Broader Market

Why health care stocks may outperform the broader market in the long run. Is now the time to consider health care stocks? Why health care is still a good way for investors to play defense. Greg Bonnell: Many health care stocks are down from the highs put in e...

XHS - Global X House Views: July 2022

Elevated inflation, slowing global economic growth expectations, and reduced central bank liquidity remain the key economic considerations. The policy interest rate divergence between the U.S. and Europe is likely to increase amid heightened recession risk in Europe. We expect mar...

XHS - Sustainable Challenges Sharpen Equity Investing Opportunities

The investment landscape has been much more difficult for most sustainable portfolios since the fourth quarter of last year. One thing that we know is that the sustainability challenges that these stocks are connected to haven’t gone away. If anything, the economic challeng...

XHS - Reimagining 'Scoping' To Save Lives

A convergence of technologies is set to revolutionize how physicians examine the body for signs of cancer. there is every reason to expect that future evolution of robotic endoluminal procedures could include the ability during the procedure to treat the cancer, either via ablation or...

Previous 10 Next 10